Skip to main content
Springer logoLink to Springer
. 2023 Dec 6;27(1):88. doi: 10.1007/s11102-023-01373-w

Correction: consensus on criteria for acromegaly diagnosis and remission

Andrea Giustina 1, Nienke Biermasz 2, Felipe F Casanueva 3, Maria Fleseriu 4, Pietro Mortini 1, Christian Strasburger 5, A J van der Lely 6, John Wass 7, Shlomo Melmed 8,; Acromegaly Consensus Group
PMCID: PMC10837242  PMID: 38052967

Correction: Pituitary

10.1007/s11102-023-01360-1.

In this article the statement in the Funding information section was incorrectly given as 'The 14th Acromegaly Consensus Conference was supported by unrestricted educational grants from Amolyt Pharma, Amryt Pharma, Basecamp Bio, Crinetics Pharmaceuticals, Ionis Pharmaceuticals, and Recordati Rare Diseases’ and should have read The 14th Acromegaly Consensus Conference was supported by unrestricted educational grants from Amolyt Pharma, Amryt Pharma, Basecamp Bio, Crinetics Pharmaceuticals, Ionis Pharmaceuticals, Novo Nordisk, Pfizer, and Recordati Rare Diseases. The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s11102-023-01360-1.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Pituitary are provided here courtesy of Springer

RESOURCES